Actiq
Links shared publicly online about this topic
FDA approves REMS for Fentora, Actiq | Oral Cancer News
oralcancernews.org — “FDA approves REMS for Fentora, Actiq | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on July 25, 2011 at 10:44 am By:
Pharma Marketing Blog: Did Cephalon Pay James Mcmillen $101,650 to Help Promote Actiq for Off-Label Use?
pharmamkting.blogspot.com — “Pharma Marketing Blog: Did Cephalon Pay James Mcmillen $101,650 to Help Promote Actiq for Off-Label Use?” View full resource at pharmamkting.blogspot.com
Most Recently Shared on February 4, 2010 at 10:09 pm By:
Did Cephalon Pay James Mcmillen $101,650 to Help Promote Actiq for Off-Label Use? http://bit.ly/aaXDZq
Why the Postal Service Is Suddenly Interested in Addictive Painkillers | BNET
bnet.com — “Cephalon once illegally marketed Actiq for injuries and migraines. Could the same thing have happened with Fentora, another of its painkiller drugs?” View full resource at bnet.com
Most Recently Shared on February 14, 2011 at 8:05 pm By:
Jim Edwards Health Communicator
Why the Postal Service Is Suddenly Interested in Addictive Painkillers: Cephalon once illegally marketed Actiq f... http://bit.ly/hg4Dfn
Cephalon's Lollipops of Death: 56 Patients at One Clinic Die of Off-Label Painkiller Use | BNET Pharma Blog | BNET
industry.bnet.com — “A Kansas case in which a doctor is accused of unlawfully prescribing Cephalon (CEPH)’s Actiq painkiller among other drugs, leading to the fatal” View full resource at industry.bnet.com
Most Recently Shared on June 12, 2010 at 12:06 am By:
Jim Edwards Health Communicator
Cephalon's Lollipops of Death: 56 Patients at One Pain Clinic Died of Off-Label Actiq Overdoses: A Kansas case in ... http://bit.ly/bqqGmA
American Academy of Pain Management e-Newsletter
aapainmanage.org — “American Academy of Pain Management e-Newsletter” View full resource at aapainmanage.org
Most Recently Shared on October 22, 2011 at 4:08 pm By:
Women In Pain Health Organization
Risk of misuse, abuse, addiction and overdose for ACTIQ and FENTORA; FDA-required restricted distribution program... http://t.co/qi27u8Z1
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
The Oral Cancer Foundation
Information- Support- Advocacy- Research- Hope The foundation is an IRS registered non-profit 501(c) 3, public service charity designed for advocacy and service, created to promote change, through proactive means, in both the public and medical/dental professional sectors. At the forefront of our agenda is the firm establishment in the minds of the American public for the need to undergo an annual oral cancer screening, combined with an outreach to the dental and medical communities to provide this service as a matter of routine practice. Oral cancer takes more lives than cancers we routinely hear about, such as cervical, Hodgkin's lymphoma, skin (malignant melanoma), testicular, and many others. In the efforts to reduce the death rate from cancers in the US, the most significant progress has been made through early detection. Cervical, skin, prostate, and others that lend themselves to simple, opportunistic screenings and exams have all had their death rates reduced through programs promoting early discovery. Early discovery and diagnosis, yields better long-term outcomes, and lower morbidity to those who undergo treatments. Oral cancer is not hidden within the body in some hard to find location requiring an invasive examination, the majority of the time it is literally in plain view, right under your nose, and can be seen with the naked eye or felt with the fingers. In most cases, its early, highly survivable stages are easily detected in a 3 to 5 minute painless visual and tactile examination. Even the precancerous lesions, which can progress into malignancy, can be seen with the naked eye. An annual oral examination conducted by members of the dental and medical communities will have a definite impact on reducing the death rate associated with oral cancer. It is our mission to bring this about.
-
John Mack
Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News
-
Jim Edwards
Writer for CBS Interactive's BNET, Adweek and Brandweek.
Advertisement
